Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24327297)

1.

Opioids for chronic refractory breathlessness: right patient, right route?

Currow DC, Ekstrom M, Abernethy AP.

Drugs. 2014 Jan;74(1):1-6. doi: 10.1007/s40265-013-0162-8. Review.

PMID:
24327297
2.

The role of benzodiazepines in breathlessness: a single site, open label pilot of sustained release morphine together with clonazepam.

Allcroft P, Margitanovic V, Greene A, Agar MR, Clark K, Abernethy AP, Currow DC.

J Palliat Med. 2013 Jul;16(7):741-4. doi: 10.1089/jpm.2012.0505. Epub 2013 Apr 18.

PMID:
23597092
3.

Opioids for refractory dyspnea.

Mahler DA.

Expert Rev Respir Med. 2013 Apr;7(2):123-34; quiz 135. doi: 10.1586/ers.13.5. Review.

PMID:
23547989
4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

Opioids for chronic refractory breathlessness: patient predictors of beneficial response.

Johnson MJ, Bland JM, Oxberry SG, Abernethy AP, Currow DC.

Eur Respir J. 2013 Sep;42(3):758-66. doi: 10.1183/09031936.00139812. Epub 2012 Dec 20.

6.

The longitudinal pattern of response when morphine is used to treat chronic refractory dyspnea.

Currow DC, Quinn S, Greene A, Bull J, Johnson MJ, Abernethy AP.

J Palliat Med. 2013 Aug;16(8):881-6. doi: 10.1089/jpm.2012.0591. Epub 2013 Jun 8.

7.

Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?

Johnson MJ, Abernethy AP, Currow DC.

J Pain Symptom Manage. 2012 Mar;43(3):614-24. doi: 10.1016/j.jpainsymman.2011.04.024. Epub 2012 Jan 30. Review.

PMID:
22285285
8.

Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study.

Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP.

J Pain Symptom Manage. 2011 Sep;42(3):388-99. doi: 10.1016/j.jpainsymman.2010.11.021. Epub 2011 Mar 31.

PMID:
21458217
9.

The active identification and management of chronic refractory breathlessness is a human right.

Currow DC, Abernethy AP, Ko DN.

Thorax. 2014 Apr;69(4):393-4. doi: 10.1136/thoraxjnl-2013-204701. Epub 2013 Nov 8.

PMID:
24212892
10.

Repeat dose opioids may be effective for breathlessness in chronic heart failure if given for long enough.

Oxberry SG, Bland JM, Clark AL, Cleland JG, Johnson MJ.

J Palliat Med. 2013 Mar;16(3):250-5. doi: 10.1089/jpm.2012.0270. Epub 2013 Jan 31.

PMID:
23368980
11.

Inhaled nebulized and intranasal opioids for the relief of breathlessness.

Bausewein C, Simon ST.

Curr Opin Support Palliat Care. 2014 Sep;8(3):208-12. doi: 10.1097/SPC.0000000000000071. Review.

PMID:
25004175
12.

Pharmacological management of dyspnoea.

Currow DC, Abernethy AP.

Curr Opin Support Palliat Care. 2007 Aug;1(2):96-101. doi: 10.1097/SPC.0b013e3282ef5e03. Review.

PMID:
18685349
13.

Neuromodulatory effect of endogenous opioids on the intensity and unpleasantness of breathlessness during resistive load breathing in COPD.

Gifford AH, Mahler DA, Waterman LA, Ward J, Kraemer WJ, Kupchak BR, Baird JC.

COPD. 2011 Jun;8(3):160-6. doi: 10.3109/15412555.2011.560132. Epub 2011 Apr 22.

PMID:
21513438
14.

Breathlessness--current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop.

Currow DC, Higginson IJ, Johnson MJ.

Palliat Med. 2013 Dec;27(10):932-8. doi: 10.1177/0269216313493819. Epub 2013 Jul 9. Review.

PMID:
23838379
15.

[Pharmacological therapy of refractory dyspnoea : a systematic literature review].

Simon ST, Köskeroglu P, Bausewein C.

Schmerz. 2012 Sep;26(5):515-22. doi: 10.1007/s00482-012-1228-3. Review. German.

PMID:
22956077
16.

Fentanyl for the relief of refractory breathlessness: a systematic review.

Simon ST, Köskeroglu P, Gaertner J, Voltz R.

J Pain Symptom Manage. 2013 Dec;46(6):874-86. doi: 10.1016/j.jpainsymman.2013.02.019. Epub 2013 Jun 4. Review.

PMID:
23742735
17.

Can we predict which patients with refractory dyspnea will respond to opioids?

Currow DC, Plummer J, Frith P, Abernethy AP.

J Palliat Med. 2007 Oct;10(5):1031-6.

PMID:
17985956
18.

Opioids, Exertion, and Dyspnea: A Review of the Evidence.

Johnson MJ, Hui D, Currow DC.

Am J Hosp Palliat Care. 2014 Oct 7. pii: 1049909114552692. [Epub ahead of print]

PMID:
25294225
19.

Chronic refractory dyspnoea--evidence based management.

Wiseman R, Rowett D, Allcroft P, Abernethy A, Currow DC.

Aust Fam Physician. 2013 Mar;42(3):137-40. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk